ES2599645T3 - Método innovador para diagnosticar la fiebre Q utilizando una prueba inmunológica celular - Google Patents

Método innovador para diagnosticar la fiebre Q utilizando una prueba inmunológica celular Download PDF

Info

Publication number
ES2599645T3
ES2599645T3 ES11745844.8T ES11745844T ES2599645T3 ES 2599645 T3 ES2599645 T3 ES 2599645T3 ES 11745844 T ES11745844 T ES 11745844T ES 2599645 T3 ES2599645 T3 ES 2599645T3
Authority
ES
Spain
Prior art keywords
fever
subject
diagnose
coxiella burnetii
cellular immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11745844.8T
Other languages
English (en)
Inventor
Leonardus Antonius Bernardus Joosten
Mihai Gheorghe Netea
Johannes Willem Maarten Van Der Meer
Bart Julian Kullberg
Marcel Van Deuren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stichting Katholieke Universiteit
Original Assignee
Stichting Katholieke Universiteit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Katholieke Universiteit filed Critical Stichting Katholieke Universiteit
Application granted granted Critical
Publication of ES2599645T3 publication Critical patent/ES2599645T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/555—Interferons [IFN]
    • G01N2333/57—IFN-gamma

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Método in vitro para diagnosticar una infección sistémica provocada por la bacteria intracelular Coxiella burnetii en un sujeto, donde dicho sujeto no ha sido vacunado con una vacuna contra la fiebre Q y donde no se sabe si dicho sujeto ha sido infectado con una bacteria de fiebre Q Coxiella burnetii, el método consiste en las siguientes etapas: (a) poner en contacto sangre obtenida de un sujeto con una fuente de un antígeno de Coxiella burnetii y (b) determinar el nivel de expresión de IFN- en dicha sangre al final de la etapa (a), donde se diagnostica una infección sistémica provocada por la bacteria intracelular Coxiella burnetii, cuando la etapa (b) lleva a un aumento de IFN- en comparación con un valor de referencia.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10

Claims (1)

  1. imagen1
ES11745844.8T 2010-08-17 2011-08-16 Método innovador para diagnosticar la fiebre Q utilizando una prueba inmunológica celular Active ES2599645T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US374313P 2002-04-19
US37431310P 2010-08-17 2010-08-17
EP10173056 2010-08-17
EP10173056 2010-08-17
PCT/NL2011/050564 WO2012023852A1 (en) 2010-08-17 2011-08-16 A novel method for diagnosing q-fever using a cellular immunological test

Publications (1)

Publication Number Publication Date
ES2599645T3 true ES2599645T3 (es) 2017-02-02

Family

ID=42676849

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11745844.8T Active ES2599645T3 (es) 2010-08-17 2011-08-16 Método innovador para diagnosticar la fiebre Q utilizando una prueba inmunológica celular

Country Status (14)

Country Link
US (1) US9551717B2 (es)
EP (1) EP2606361B1 (es)
AU (1) AU2011292497B2 (es)
BR (1) BR112013003557A2 (es)
CA (1) CA2808998A1 (es)
CL (1) CL2013000443A1 (es)
ES (1) ES2599645T3 (es)
HU (1) HUE031695T2 (es)
IL (1) IL224765A (es)
MA (1) MA34472B1 (es)
MX (1) MX2013001843A (es)
PL (1) PL2606361T3 (es)
WO (1) WO2012023852A1 (es)
ZA (1) ZA201301211B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014142646A1 (en) 2013-03-13 2014-09-18 Stichting Katholieke Universiteit Q-fever diagnostic

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9011861D0 (en) 1990-05-26 1990-07-18 Beecham Group Plc Novel compounds
US5723286A (en) 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
JP3672306B2 (ja) 1991-04-10 2005-07-20 ザ スクリップス リサーチ インスティテュート ファージミドを使用するヘテロ二量体受容体ライブラリー
WO1998047343A2 (en) 1997-04-04 1998-10-29 Biosite Diagnostics, Inc. Antibodies or binding protein libraries displayed on phage, cells, or other replicatable genetic packages

Also Published As

Publication number Publication date
PL2606361T3 (pl) 2017-02-28
US9551717B2 (en) 2017-01-24
ZA201301211B (en) 2014-07-30
EP2606361A1 (en) 2013-06-26
MX2013001843A (es) 2013-06-28
US20130210038A1 (en) 2013-08-15
IL224765A (en) 2017-10-31
CA2808998A1 (en) 2012-02-23
AU2011292497B2 (en) 2015-10-15
WO2012023852A1 (en) 2012-02-23
CL2013000443A1 (es) 2014-01-17
AU2011292497A1 (en) 2013-03-07
HUE031695T2 (en) 2017-07-28
EP2606361B1 (en) 2016-08-10
MA34472B1 (fr) 2013-08-01
BR112013003557A2 (pt) 2018-03-27

Similar Documents

Publication Publication Date Title
ES2628944T3 (es) Método para la evaluación de la función de fagocitos
EP2549763A3 (en) Dual image capture processing
EP2701193A3 (en) Light emitting device
AR082529A1 (es) FORMULACIONES ESTABLES DE ANTIGENOS rLP2086 DE NEISSERIA MENINGITIDIS
PE20190458A1 (es) Composiciones de neisseria meningitidis y metodos de las mismas
EP2562556A3 (en) Magnetic sensor with low electric offset
ES2539390T3 (es) Material refractario colado fundido a base de óxido de aluminio, dióxido de zirconio y dióxido de silicio, y utilización de dicho material
EP2384026A3 (en) Acoustic sensor and method of manufacturing the same
MX2010014228A (es) Metodos y productos de diagnostico del p/gf-1 acompañante.
WO2007052059A3 (en) Changing th1/th2 balance in split influenza vaccines with adjuvants
MX2015013832A (es) Composicion de vacuna y metodo de uso.
CL2012001293A1 (es) Uso del compuesto 2-(4-metilfenil)-6-(metil)quinolina para inhibor la agragacion de la proteina tau en una persona dque sufre alzheimer
ES2599645T3 (es) Método innovador para diagnosticar la fiebre Q utilizando una prueba inmunológica celular
EP2720043A3 (en) HMGB1 and anti-HMGB1 antibodies for the prognosis of neurological disorders
ES2578160T3 (es) Procedimiento de diagnóstico de infecciones de sitio quirúrgico
EP2431781A3 (en) Ranging apparatus, lens system, and imaging apparatus
AR098194A1 (es) Ensayos de líneas de células t de humanos para evaluar la identidad inmunológica de preparaciones de acetato de glatiramero
RU2009130524A (ru) Способ диагностики пищевой аллергии
RU2008118673A (ru) Способ определения коэффициента полезного действия зубчатой передачи
RU2010148706A (ru) Способ определения повышения уровня гистамина в крови беременных под влиянием нарастания активности аргининдегидрогеназы в синцитиотрофобласте ворсинок плаценты, вызванной обострением в третьем триместре гестации герпес-вирусной инфекции
ES2533924T3 (es) Composiciones y métodos para detectar ácidos nucleicos específicos de patógenos en la orina
EP2642148A3 (en) A method for hydraulically filling a clutch without using a calibration routine
ES2488140T3 (es) Uso de fosfolipasas A2 secretadas en el diagnóstico y tratamiento de la malaria
RU2009134577A (ru) Способ определения тяговой мощности транспортного средства при его испытании в тяговом режиме трогания с места
RU2010116865A (ru) Способ измерения внутриглазного давления